LivingGLP1
Study S001942

The Effect of Semaglutide on the Intestinal Flora in Obesity

Registration

Registration
NCT07323134
Study type
OBSERVATIONAL
Status
NOT_YET_RECRUITING
Enrollment
40
Start
2026-02-01
Primary completion
2026-08-01
Lead sponsor
Beijing Chao Yang Hospital
Conditions
Obesity
Interventions
DRUG:Semaglutide Injection
Results posted
FALSE

Registered primary outcomes

  • The composition of the gut microbiota changes relative to the baseline [Baseline,4weeks,8weeks,12weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.